Literature DB >> 2106778

Rapid immunoperoxidase demonstration of Rickettsia rickettsii in fixed cutaneous specimens from patients with Rocky Mountain spotted fever.

J S Dumler1, W R Gage, G L Pettis, A F Azad, F P Kuhadja.   

Abstract

Immunofluorescence (IF) of skin biopsies for detection of Rickettsia rickettsii (RR) has proven useful as a rapid test for confirmation of Rocky Mountain spotted fever (RMSF). However, IF lacks sensitivity, requires special equipment and training, and is difficult to interpret. The authors have developed an indirect avidin-biotin immunoperoxidase (IP) technique to detect RR in fixed and frozen tissue sections. The technique was evaluated on fixed cutaneous specimens from patients dying of RMSF and compared to specimens from control patients dying of an acute febrile illness with skin manifestations and vasculitis. IP correctly identified RR in 9 of 12 cases with probable identification in 2 additional cases. Of 11 controls, 10 were negative and one was uninterpretable. RR was easily visualized within cytoplasm and nuclei of endothelial cells in association with perivascular lymphocytic infiltrates and less frequently with vasculitis or non-inflamed vasculature. IP is rapid, amplifies small quantities of antigen, gives excellent histologic detail as compared with IF, and is easily adapted for use in hospitals with immunoperoxidase capabilities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106778     DOI: 10.1093/ajcp/93.3.410

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

Review 1.  Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

2.  Routine argyrophil techniques detect Rickettsia rickettsii in tissues of patients with fatal Rocky Mountain spotted fever.

Authors:  Christopher D Paddock; Jeanine H Sanders; Amy M Denison; Atis Muehlenbachs; Sherif R Zaki
Journal:  J Histotechnol       Date:  2016-12-12       Impact factor: 0.714

3.  Rocky Mountain spotted fever following cardiac transplantation.

Authors:  T M Rallis; J D Kriesel; J S Dumler; L E Wagoner; E D Wright; S L Spruance
Journal:  West J Med       Date:  1993-06

Review 4.  Tick-borne encephalopathies : epidemiology, diagnosis, treatment and prevention.

Authors:  Göran Günther; Mats Haglund
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 5.  Rickettsioses as paradigms of new or emerging infectious diseases.

Authors:  D Raoult; V Roux
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

6.  Rickettsia australis infection: a murine model of a highly invasive vasculopathic rickettsiosis.

Authors:  H M Feng; J Wen; D H Walker
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  Depletion of gamma interferon and tumor necrosis factor alpha in mice with Rickettsia conorii-infected endothelium: impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease.

Authors:  H M Feng; V L Popov; D H Walker
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Detection of Ehrlichia chaffeensis in human tissue by using a species-specific monoclonal antibody.

Authors:  X Yu; P Brouqui; J S Dumler; D Raoult
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

9.  Lymph node hemophagocytosis in rickettsial diseases: a pathogenetic role for CD8 T lymphocytes in human monocytic ehrlichiosis (HME)?

Authors:  Kerry L Dierberg; J Stephen Dumler
Journal:  BMC Infect Dis       Date:  2006-07-21       Impact factor: 3.090

10.  Fatal spotted fever rickettsiosis, Minas Gerais, Brazil.

Authors:  Márcio Antonio Moreira Galvâo; J Stephen Dumler; Cláudio Lísias Mafra; Simone Berger Calic; Chequer Buffe Chamone; Gracco Cesarino Filho; Juan Pablo Olano; David H Walker
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.